Kairos Pharma KAPA
NYSE KAPA
$0.49 -0.01 (-3.01%)
As of: Nov 10, 2026 · 3:53 PM EST

Kairos Pharma (KAPA) Common Equity (2023 - 2025)

Updated

Kairos Pharma (KAPA) recorded Common Equity of $6.34 million in Q4 2025, up 32.8% from $4.78 million a year earlier.

Analysis

Kairos Pharma (KAPA) Common Equity (2023 - 2025) Analysis & Trends

Starting with Q3 2023, Kairos Pharma's Common Equity history includes 9 quarters.

  • Across earlier years, Common Equity came in at $4.78 million in FY2024 and -$2.08 million in FY2023.
  • Quarterly Common Equity has ranged from -$2.65 million in Q2 2024 to $7.13 million in Q1 2025 over the past five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn 40.27 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn 81.53 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn -4.58 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn 44.95 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn 41.95 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn 50.37 Bn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn 14.35 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn 13.04 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn 89.30 Bn
10 Kairos Pharma 9.22 Mn -3.20 Mn - 6.34 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 6.34 Mn
Jun 30, 2025 6.00 Mn
Mar 31, 2025 7.13 Mn
Dec 31, 2024 4.78 Mn
Sep 30, 2024 3.33 Mn
Jun 30, 2024 -2.65 Mn
Mar 31, 2024 -2.40 Mn
Dec 31, 2023 -2.08 Mn
Sep 30, 2023 -1.87 Mn
API Access

Kairos Pharma Common Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=common-equity&ticker=KAPA&period=max&api_key=YOUR_API_KEY